Pharma stocks such as Sun Pharma, Cipla, Dr Reddy’s Laboratories, Lupin, and others will be in focus on Wednesday after US President Donald Trump said tariffs on imported pharmaceuticals could rise to as high as 250%. The proposed tariffs would start at a lower rate but escalate over time, he said in a CNBC interview.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets